73 related articles for article (PubMed ID: 28561692)
21. Patient-reported outcomes in patients with hematological relapse or progressive disease: a longitudinal observational study.
Sommer M; Nielsen LK; Nielsen LB; Brøndum RF; Nielsen MM; Rytter AS; Vesteghem C; Severinsen MT; El-Galaly TC; Bøgsted M; Grønkjær M; Jørgensen L
Health Qual Life Outcomes; 2021 Nov; 19(1):251. PubMed ID: 34736479
[TBL] [Abstract][Full Text] [Related]
22. Follicular lymphoma.
Carbone A; Roulland S; Gloghini A; Younes A; von Keudell G; López-Guillermo A; Fitzgibbon J
Nat Rev Dis Primers; 2019 Dec; 5(1):83. PubMed ID: 31831752
[TBL] [Abstract][Full Text] [Related]
23. Increased risk of lymphoid malignancy in patients with herpes zoster: a longitudinal follow-up study using a national cohort.
Choi HG; Zehnder JL; Lee YK; Lim H; Kim M
BMC Cancer; 2019 Nov; 19(1):1148. PubMed ID: 31775678
[TBL] [Abstract][Full Text] [Related]
24. Lymphoma epidemiology in Korea and the real clinical field including the Consortium for Improving Survival of Lymphoma (CISL) trial.
Yoo KH; Lee H; Suh C;
Int J Hematol; 2018 Apr; 107(4):395-404. PubMed ID: 29357080
[TBL] [Abstract][Full Text] [Related]
25. Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.
Jaime-Pérez JC; Gamboa-Alonso CM; Vázquez-Mellado de Larracoechea A; Rodríguez-Martínez M; Gutiérrez-Aguirre CH; Marfil-Rivera LJ; Gómez-Almaguer D
Arch Med Res; 2015 Aug; 46(6):454-61. PubMed ID: 26235285
[TBL] [Abstract][Full Text] [Related]
26. Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients.
Caimi PF; William BM; Silva Rondon CH; Fu P; Cooper BW; Campagnaro EL; Gerson SL; Reese-Koc J; Fox R; Creger RJ; de Lima M; Lazarus HM
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1926-31. PubMed ID: 26087475
[TBL] [Abstract][Full Text] [Related]
27. [The use of nitrogen mustard in the treatment of lymphatic diseases of a malignant type].
RABENKO J; CORREA URQUIZA LM
Prensa Med Argent; 1959 Oct; 46():2549-54. PubMed ID: 14435621
[No Abstract] [Full Text] [Related]
28. Economic burden and treatment patterns for patients with diffuse large B-cell lymphoma and follicular lymphoma in the USA.
Ren J; Asche CV; Shou Y; Galaznik A
J Comp Eff Res; 2019 Apr; 8(6):393-402. PubMed ID: 30855175
[TBL] [Abstract][Full Text] [Related]
29. Health Disparities and the Global Landscape of Lymphoma Care Today.
Phillips AA; Smith DA
Am Soc Clin Oncol Educ Book; 2017; 37():526-534. PubMed ID: 28561692
[TBL] [Abstract][Full Text] [Related]
30. Transformed follicular non-Hodgkin lymphoma.
Casulo C; Burack WR; Friedberg JW
Blood; 2015 Jan; 125(1):40-7. PubMed ID: 25499449
[TBL] [Abstract][Full Text] [Related]
31. [Hodgkin and non-Hodgkin lymphoma of adolescents and young adults].
Garciaz S; Coso D; Brice P; Bouabdallah R
Bull Cancer; 2016 Dec; 103(12):1035-1049. PubMed ID: 27866679
[TBL] [Abstract][Full Text] [Related]
32. [Current treatment for malignant lymphomas].
Usui N
Gan To Kagaku Ryoho; 2007 Dec; 34(13):2191-9. PubMed ID: 18079619
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
